What is the staging process leading to walled-off necrosis (WON) in acute pancreatitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Staging Process Leading to Walled-Off Necrosis (WON)

WON develops through a predictable temporal evolution over approximately 4 weeks following the onset of acute necrotizing pancreatitis, progressing from acute necrotic collections to mature, encapsulated collections with well-defined inflammatory walls. 1

Timeline and Evolution

The staging process follows a clear temporal sequence:

Week 1-4: Acute Necrotic Collection (ANC) Phase

  • Necrosis of pancreatic parenchyma and/or peripancreatic tissues occurs in 10-20% of patients with acute pancreatitis during the initial inflammatory phase. 2
  • During the first 4 weeks after disease onset, necrotic tissue remains unencapsulated and is classified as an acute necrotic collection (ANC). 3, 4
  • This early phase is characterized by poorly demarcated necrotic debris mixed with fluid, without a defined wall. 4
  • Approximately one-third of deaths occur during this early phase, primarily from multiple organ failure rather than infection. 5, 6

Week 4 and Beyond: WON Formation

  • After 4 weeks or more from the onset of acute pancreatitis, the collection matures into walled-off necrosis, characterized by a well-defined, enhancing inflammatory wall that encapsulates the pancreatic and/or peripancreatic necrosis. 1
  • This maturation process creates a distinct capsule that separates the necrotic material from surrounding tissues. 3, 7
  • The collection becomes heterogeneous, containing varying amounts of liquid and solid necrotic material. 7
  • WOPN was formerly termed "pancreatic abscess" under older classification systems. 8

Key Pathophysiologic Stages

Initial Inflammatory Response

  • Acute pancreatitis triggers acinar cell destruction and acute inflammation of the pancreas. 1
  • The severity determines whether necrosis develops—most patients (80-85%) develop mild disease without necrosis. 1

Necrosis Development

  • In 10-20% of cases, necrosis extends into pancreatic parenchyma and/or peripancreatic tissues. 2
  • The extent of necrosis directly correlates with mortality risk and complications. 6

Encapsulation Process

  • Over 4 weeks, granulation tissue forms around the necrotic collection, creating the characteristic inflammatory wall. 1
  • This wall formation distinguishes WON from earlier acute necrotic collections. 3

Clinical Implications of Staging

The 4-week threshold is critical because interventions for infected necrosis should be delayed until this maturation occurs whenever possible, as this timing results in lower mortality. 5

Management Based on Stage

  • During the ANC phase (weeks 1-4): Focus on supportive care including fluid resuscitation, early enteral nutrition, and monitoring for complications. 5
  • After WON formation (≥4 weeks): Intervention may be considered if the collection becomes infected or symptomatic, using a step-up approach starting with percutaneous or endoscopic drainage. 5, 2

Infection Risk by Stage

  • Infection of pancreatic necrosis occurs in 20-40% of patients with severe acute pancreatitis, typically after 7-10 days of illness. 5, 6
  • Infected necrosis with organ failure carries mortality rates of 35.2%, while infected necrosis without organ failure has mortality of only 1.4%. 6

Imaging Correlation with Staging

  • Contrast-enhanced CT or MRI should be performed 72-96 hours after symptom onset to assess for necrosis development. 6
  • Early imaging may underestimate the extent of necrosis before full demarcation occurs. 8
  • MRI and endoscopic ultrasound are superior for evaluating solid necrotic debris within collections. 7

Common Pitfalls

Avoid intervening too early (before 4 weeks) unless absolute indications exist, such as abdominal compartment syndrome unresponsive to conservative management, acute ongoing bleeding when endovascular approach fails, or bowel ischemia. 5 Early intervention before wall maturation increases morbidity and mortality compared to delayed intervention after WON formation. 2, 8

References

Guideline

2019 wses guidelines for the management of severe acute pancreatitis.

World Journal of Emergency Surgery, 2019

Guideline

acr appropriateness criteria® radiologic management of infected fluid collections.

Journal of the American College of Radiology, 2020

Guideline

Management of Necrotizing Pancreatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Prognosis of Acute Necrotizing Pancreatitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

An overview of walled-off pancreatic necrosis for clinicians.

Expert review of gastroenterology & hepatology, 2019

Research

Walled-off pancreatic necrosis.

World journal of gastroenterology, 2010

Related Questions

What is walled‑off necrosis, its clinical presentation, and recommended management?
What is the mortality rate for acute necrotizing pancreatitis?
What is the diagnosis and treatment for necrotizing pancreatitis (inflammation of the pancreas with tissue death)?
In a patient with acute necrotising pancreatitis, what does the double‑duct sign (simultaneous dilation of the common bile duct and pancreatic duct) indicate and what is the recommended diagnostic and therapeutic approach?
What is the prognosis of acute necrotizing pancreatitis?
What is the next step in managing a patient with a 1-month history of recurrent cough, previously diagnosed with bronchitis, unresponsive to Cefuroxime (Cefuroxime) and Levofloxacin (Levofloxacin), with a chest X-ray (CXR) showing no pneumonia?
Can urinary symptoms, such as urinary retention or obstructive uropathies, cause bilateral leg swelling in a patient?
What are the treatment options for a patient with shingles who has already received acyclovir and requires retreatment?
What is the best way to care for a long-term urinary catheter in an elderly patient with limited mobility and a chronic medical condition, such as spinal cord injury, multiple sclerosis, or benign prostatic hyperplasia (BPH)?
Is Estradiol (estradiol) Vaginal Cream safe for a post-transplant patient?
What is the recommended management plan for a patient under 40 with familial Carney complex, considering their genetic predisposition and potential for cardiac myxomas, endocrine tumors, and other manifestations?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.